Side-by-side comparison of AI visibility scores, market position, and capabilities
Alphabet/DeepMind drug discovery spinoff. $600M from Thrive Capital. Drug Design Engine doubled AlphaFold3 accuracy. Preparing first clinical trials.
Isomorphic Labs is an Alphabet company spun out of Google DeepMind to apply AI to the full drug discovery pipeline, from target identification through molecular design and clinical candidate selection. Founded in 2021 under CEO Demis Hassabis's vision of using AI to accelerate medicine, Isomorphic operates with the scientific resources and computational infrastructure of DeepMind while functioning as a standalone drug discovery organization. The company's founding mission is to use AI not merely as a tool to assist drug hunters, but as the primary engine of drug design — replacing the slow, expensive, and largely empirical process of traditional medicinal chemistry with AI-directed molecular engineering.\n\nIsomorphic's core platform is the Drug Design Engine, a proprietary AI system built on top of AlphaFold architecture. The Drug Design Engine has achieved landmark performance results, reportedly doubling the accuracy of AlphaFold3 at predicting how small molecules bind to their protein targets — the fundamental problem in structure-based drug design. This capability enables Isomorphic to computationally design molecules predicted to bind their targets with far greater precision than conventional methods, potentially eliminating many of the expensive iterative cycles that make drug development so slow. The company has also established major pharma partnerships with Eli Lilly and Novartis to co-develop drug candidates across multiple therapeutic areas.\n\nIsomorphic raised $600M from Thrive Capital in 2024–2025, bringing substantial private capital alongside its Alphabet backing to accelerate pipeline development. As of 2026, the company is preparing for its first clinical trials — a critical milestone that will test whether its computational drug design predictions translate into human efficacy. With AlphaFold-derived technology at its core, partnerships with two of the world's largest pharmaceutical companies, and over half a billion in funding, Isomorphic Labs represents the most credentialed and well-resourced pure-play AI drug discovery company in existence.
Tesla (TSLA) reported $97.7B revenue in FY2024, up 1% YoY. 1.8M vehicles delivered. Market cap ~$900B. 140,000+ employees. Austin, TX. FSD (Full Self-Driving), Optimus humanoid robot, Dojo AI training supercomputer.
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as chairman and lead investor in 2004. The company was built on the premise that electric vehicles could be desirable, high-performance automobiles — not compromise products — and that compelling EVs would accelerate the world's transition to sustainable energy. Musk's strategy, articulated in the 2006 "Secret Master Plan," was to start with a premium sports car (Roadster), use the proceeds to build a more affordable sedan (Model S), and ultimately produce a mass-market vehicle (Model 3). Tesla trades on Nasdaq under the ticker TSLA and has since expanded its mission to encompass solar energy, stationary storage, and autonomous driving.\n\nTesla's product portfolio spans the Model 3 (sedan), Model Y (compact SUV — the world's best-selling vehicle in 2023), Model S (premium sedan), Model X (premium SUV), Cybertruck (full-size electric pickup), and the Tesla Semi commercial truck. The company's energy business includes the Powerwall home battery, Megapack utility-scale storage, and Solar Roof installations. Tesla's Full Self-Driving (FSD) software suite provides driver assistance capabilities up to supervised autonomous driving, with a paid subscription and per-vehicle purchase option. Tesla operates a proprietary Supercharger network of 50,000+ charging stations globally, a significant infrastructure moat that has become accessible to competing EV brands through industry NACS adapter adoption.\n\nTesla reported FY2024 revenue of $97.7 billion, up approximately 1% year over year, with 1.8 million vehicles delivered and a market capitalization of approximately $900 billion — making it one of the ten most valuable companies in the world. The company employs 140,000+ people and operates Gigafactories in Austin (Texas), Fremont (California), Shanghai, Berlin, and Nevada. Despite increasing competition from BYD in China and European automakers globally, Tesla's vertical integration, software-defined vehicle architecture, FSD capability, and energy storage business position it as the defining company of the electric transportation and distributed energy era.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.